41616-97-1

Basic information

• Product Name: Benzothiazolium, 3-ethyl-5-methoxy-2-methyl-, iodide
• CAS NO: 41616-97-1
• Molecular Formula: C11H14NOS.I
• Molecular Weight: 335.209
• Mol File: 41616-97-1.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzothiazolium, 3-ethyl-5-methoxy-2-methyl-, iodide(CAS DataBase Reference)
• NIST Chemistry Reference: Benzothiazolium, 3-ethyl-5-methoxy-2-methyl-, iodide(41616-97-1)
• EPA Substance Registry System: Benzothiazolium, 3-ethyl-5-methoxy-2-methyl-, iodide(41616-97-1)

Safety Data

• Hazardous Substances Data: 41616-97-1(Hazardous Substances Data)

Upstream product

• 2941-69-7 5-methoxy-2-methylbenzo[d]thiazole 
• 75-03-6 ethyl iodide 

Downstream Products

• 719277-26-6 TG003 
• 84626-20-0 3,3'-diethyl-5,5'-dimethoxy-11-methyl-10,12-trimethylenethiatricarbocyanine iodide 
• 34543-63-0 1,5-bis-(3-ethyl-5-methoxy-benzothiazol-2-yl)-2-phenyl-pentamethinium; iodide 

Relevant articles and documents

INHIBITORS OF CDC2-LIKE KINASES (CLKS) AND METHODS OF USE THEREOF

Provided herein are compounds which are CDC2-Like Kinase (CLK) inhibiting compounds and methods of use thereof. The CLK-inhibiting compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and d

Therapeutic composition of treating abnormal splicing caused by the excessive kinase induction

The present invention provides a composition of treating, preventing abnormal splicing caused by the excessive kinase induction, which comprises TG003 and a method using the same of treating, preventing abnormal splicing caused by the excessive kinase induction.